Investment
Features
FeesSafety
Academy
More
Pluang+

Compare LyondellBasell Industries NV (LYB) vs Twist Bioscience Corp (TWST) Price & Performance

LyondellBasell Industries NVTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

LyondellBasell Industries NV vs Twist Bioscience Corp — how do they compare? LyondellBasell Industries NV trades at $63.98 (market cap $20.67B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: LyondellBasell Industries NV is far larger — about 2.7× Twist Bioscience Corp's market cap, and LyondellBasell Industries NV pays a 6.44% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.

LYBTWST
Market Cap
$20.67B$7.72B
Sector
Basic MaterialsHealth
52-Week High
$82.38$124.88
52-Week Low
$42.28$24.16
Enterprise Value
$32.26B$7.65B
Dividend Yield
6.44%

Returns comparison

Trailing returns across standard periods

About LyondellBasell Industries NV

LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.

Read more on LYB

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST